EFFICACY, TOLERABILITY AND SAFETY OF PROPIVERINE HYDROCHLORIDE IN COMPARISON TO OXYBUTYNIN IN CHILDREN WITH NEUROGENIC DETRUSOR OVERACTIVITY – A MULTICENTER OBSERVATIONAL COHORT STUDY
Madersbacher H1, Muertz G2, Alloussi S3, Domurath B4, Henne T5, Koerner I6, Niedeggen A7, Nounla J8, Schuldt M9, Schulte-baukloh H7, Stuckert T10, Bock P11 1. Neurourology Unit, University of Innsbruck, Austria, 2. Dresden, Germany, 3. Neunkirchen, Germany, 4. Bad Wildungen, Germany, 5. Hamburg, Germany, 6. Essen, Germany, 7. Berlin, Germany, 8. Leipzig, Germany, 9. Greifswald, Germany, 10. Zwickau, Germany, 11. Basel, Switzerland
|
Abstract 259
|
|
Non Discussion Posters
Scientific Non Discussion Poster Session 17
|
|